Pacific Biosciences
PACB
PACB
128 hedge funds and large institutions have $580M invested in Pacific Biosciences in 2016 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 42 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
21% less call options, than puts
Call options by funds: $5.52M | Put options by funds: $7M
39% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 31
Holders
128
Holding in Top 10
3
Calls
$5.52M
Puts
$7M
Top Buyers
| 1 | +$16.3M | |
| 2 | +$12.8M | |
| 3 | +$11.4M | |
| 4 |
RCM
Raging Capital Management
Rocky Hill,
New Jersey
|
+$9.61M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$6.72M |
Top Sellers
| 1 | -$25.3M | |
| 2 | -$8M | |
| 3 | -$7.84M | |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$3.14M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$2.84M |